NasdaqCM - Delayed Quote USD
Oncternal Therapeutics, Inc. (ONCT)
0.5266
-0.1674
(-24.12%)
At close: December 2 at 4:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
36,729
68,651
93,585
118,809
Total Liabilities Net Minority Interest
6,677
7,682
5,465
5,858
Total Equity Gross Minority Interest
30,052
60,969
88,120
112,951
Total Capitalization
30,052
60,969
88,120
112,951
Common Stock Equity
30,052
60,969
88,120
112,951
Capital Lease Obligations
318
87
75
40
Net Tangible Assets
30,052
60,969
88,120
112,951
Working Capital
30,861
59,608
87,388
112,145
Invested Capital
30,052
60,969
88,120
112,951
Tangible Book Value
30,052
60,969
88,120
112,951
Total Debt
318
87
75
40
Share Issued
2,948
2,873.2000
2,471.4500
2,440.1000
Ordinary Shares Number
2,948
2,873.2000
2,471.4500
2,440.1000
12/31/2020 - 2/3/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
27F0.F KALA BIO, Inc.
2.6120
-7.64%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
THAR Tharimmune, Inc.
1.2052
+3.90%
AFMD Affimed N.V.
0.7703
+4.24%
IKNA Ikena Oncology, Inc.
1.2100
+1.68%
STTK Shattuck Labs, Inc.
0.8513
-4.68%
PBLA Panbela Therapeutics, Inc.
0.3430
+22.50%
TRDA Entrada Therapeutics, Inc.
8.71
0.00%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
ELDN Eledon Pharmaceuticals, Inc.
3.3600
-0.59%